Epen Tablet (Eperisone Hydrochloride)

Adult dose

Administer 50 mg of Eperisone Hydrochloride orally three times a day after meals. Adjust the dosage properly according to age and symptoms.

This drug should not be used in certain patients. First, patients with a history of allergic reactions to this drug should not be administered. Second, patients with severe myasthenia gravis should also not take this drug. Third, this drug contains lactose, so it should not be given to patients with a genetic lactose intolerance. Fourth, patients with a history of allergy to soybean oil, soy, or peanuts should avoid this drug. Additionally, this drug should be administered with caution in some patients. Patients with a history of drug allergies or liver function issues may experience worsening liver function, so caution is required. Patients with lipid metabolism disorders, such as hyperlipidemia, diabetic dyslipidemia, or pancreatitis, or those on medications containing lipid components should also be careful. There may be rare side effects such as shock, so symptoms should be closely monitored. Liver dysfunction, kidney dysfunction, and blood abnormalities can also occur infrequently, thus caution is necessary. Reports of skin rashes or itching, psychiatric symptoms (insomnia, drowsiness, headache, etc.), and gastrointestinal symptoms (nausea, vomiting, loss of appetite, etc.) have been documented. Urinary symptoms, systemic weakness, and dizziness may also occur; any abnormal symptoms should be reported immediately. If any severe skin reactions, such as toxic epidermal necrolysis or Stevens-Johnson syndrome, occur, usage should be stopped immediately and treatment sought. Generally, during the course of this medication, symptoms such as drowsiness, weakness, and dizziness may manifest; dosage should be reduced or stopped if these symptoms occur. Drowsiness or decreased concentration may occur, so driving or operating dangerous machinery should be avoided. Patients with lipid metabolism issues should have their blood lipid levels monitored regularly to adjust the dosage of this medication accordingly. In particular, those using other lipid injectable medications should adjust the dosages with consideration of total lipid content. Caution should be exercised when taking this drug in conjunction with similar medications or specific muscle relaxants, as timing disorders may occur. Pregnant women or women of childbearing potential should only take this medication when the benefits of treatment outweigh the risks, as its safety is not established. Breastfeeding women should avoid taking this medication; if necessary, breastfeeding should be discontinued. Safety in children has not been sufficiently established, so caution is needed when used by them. Elderly patients should be carefully managed as body functions may be decreased, and doses should be reduced accordingly.

Serious side effects

Shock (severe allergic reaction), anaphylaxis (severe allergic reaction), angioedema (severe allergic reaction), toxic epidermal necrolysis and mucocutaneous and ocular syndrome (severe skin reaction), severe rashes with fever and blisters, conjunctival injection, stomatitis (severe skin reaction), elevation of ALT, AST, ALP (liver dysfunction), jaundice of the skin or eyes (liver dysfunction), proteinuria, elevation of BUN (kidney dysfunction).

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• limb paralysis
• rigidity of the body
• limb tremors
• nausea
• vomiting

This drug should be stored in a tightly sealed container that is air-tight, and it is recommended to keep it at room temperature between 1 degree and 30 degrees. This method helps maintain the drug's effectiveness.

Appearance

For domestic use: white round film-coated tablets For export: reddish-orange round film-coated tablets

Package unit

For domestic use: 30 tablets/bottle, 1,000 tablets/bottle For export: 100 tablets (10 tablets/PTP x 10)